tetano
Editor, Senior Moderator
Inflamm Res
. 2022 Jun 25.
doi: 10.1007/s00011-022-01596-w. Online ahead of print.
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
Shima Makaremi[SUP] #[/SUP][SUP] 1 2 [/SUP], Ali Asgarzadeh[SUP] #[/SUP][SUP] 3 2 [/SUP], Hamed Kianfar[SUP] 3 2 [/SUP], Alireza Mohammadnia[SUP] 2 [/SUP], Vahid Asghariazar[SUP] 2 [/SUP], Elham Safarzadeh[SUP] 4 5 [/SUP]
Affiliations
Abstract
A global pandemic has erupted as a result of the new brand coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This pandemic has been consociated with widespread mortality worldwide. The antiviral immune response is an imperative factor in confronting the recent coronavirus disease 2019 (COVID-19) infections. Meantime, cytokines recognize as crucial components in guiding the appropriate immune pathways in the restraining and eradication of the virus. Moreover, SARS-CoV-2 can induce uncontrolled inflammatory responses characterized by hyper-inflammatory cytokine production, which causes cytokine storm and acute respiratory distress syndrome (ARDS). As excessive inflammatory responses are contributed to the severe stage of the COVID-19 disease, therefore, the pro-inflammatory cytokines are regarded as the Achilles heel during COVID-19 infection. Among these cytokines, interleukin (IL-) 1 family cytokines (IL-1, IL-18, IL-33, IL-36, IL-37, and IL-38) appear to have a strong inflammatory role in severe COVID-19. Hence, understanding the underlying inflammatory mechanism of these cytokines during infection is critical for reducing the symptoms and severity of the disease. Here, the possible mechanisms and pathways involved in inflammatory immune responses are discussed.
Keywords: COVID-19; Inflammation; Interleukin-1 family; Interleukin-18; Interleukin-33.
. 2022 Jun 25.
doi: 10.1007/s00011-022-01596-w. Online ahead of print.
The role of IL-1 family of cytokines and receptors in pathogenesis of COVID-19
Shima Makaremi[SUP] #[/SUP][SUP] 1 2 [/SUP], Ali Asgarzadeh[SUP] #[/SUP][SUP] 3 2 [/SUP], Hamed Kianfar[SUP] 3 2 [/SUP], Alireza Mohammadnia[SUP] 2 [/SUP], Vahid Asghariazar[SUP] 2 [/SUP], Elham Safarzadeh[SUP] 4 5 [/SUP]
Affiliations
- PMID: 35751653
- DOI: 10.1007/s00011-022-01596-w
Abstract
A global pandemic has erupted as a result of the new brand coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This pandemic has been consociated with widespread mortality worldwide. The antiviral immune response is an imperative factor in confronting the recent coronavirus disease 2019 (COVID-19) infections. Meantime, cytokines recognize as crucial components in guiding the appropriate immune pathways in the restraining and eradication of the virus. Moreover, SARS-CoV-2 can induce uncontrolled inflammatory responses characterized by hyper-inflammatory cytokine production, which causes cytokine storm and acute respiratory distress syndrome (ARDS). As excessive inflammatory responses are contributed to the severe stage of the COVID-19 disease, therefore, the pro-inflammatory cytokines are regarded as the Achilles heel during COVID-19 infection. Among these cytokines, interleukin (IL-) 1 family cytokines (IL-1, IL-18, IL-33, IL-36, IL-37, and IL-38) appear to have a strong inflammatory role in severe COVID-19. Hence, understanding the underlying inflammatory mechanism of these cytokines during infection is critical for reducing the symptoms and severity of the disease. Here, the possible mechanisms and pathways involved in inflammatory immune responses are discussed.
Keywords: COVID-19; Inflammation; Interleukin-1 family; Interleukin-18; Interleukin-33.